AMS and Ethicon in patent pact:
This article was originally published in Clinica
American Medical Systems (AMS) has entered into a cross-licensing agreement with Ethicon's Gynecare worldwide division involving patents in the field of female pelvic health. AMS, of Minnetonka, Minnesota, recently received US FDA clearance for its Perigee device, the first minimally invasive surgical system for repairing bladder prolapse in women (see Clinica No 1111, p 18). Gynecare's product portfolio addresses female health issues, such as excessive menstrual bleeding, fibroids and polyps and incontinence.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.